Abstract
免疫检查点抑制剂（ICI）能阻断肿瘤的免疫逃逸机制，其临床适应证在不断扩展，极大地改善了多种晚期恶性肿瘤患者的临床预后，但免疫相关不良事件的报道也随之增加。心包疾病是最常见ICI相关心血管不良反应，起病隐匿，在急性期具有高致死率。该综述展示了近几年来ICI相关心包疾病的发病概况、致病机制、临床表现、监测和处理原则等方面的研究进展，以期提高临床医师对该疾病的认识和应对能力。.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
